APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meloxicam Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Meloxicam Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchMeloxicam Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Meloxicam Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Meloxicam Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meloxicam Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Meloxicam Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Meloxicam Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meloxicam Drugs include Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Nipro, Novitium Pharma, Zydus, Jiangsu Jibeier Pharmaceutical, Kelun Pharmaceutical and Luye Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meloxicam Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meloxicam Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meloxicam Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meloxicam Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Meloxicam Drugs Segment by Company

Boehringer Ingelheim

Iroko Pharmaceuticals

Lupin

Nipro

Novitium Pharma

Zydus

Jiangsu Jibeier Pharmaceutical

Kelun Pharmaceutical

Luye Pharma

Qilu Pharmaceutical

Simcere Pharmaceutical

Yangtze River Pharmaceutical

YaoPharma

Zhejiang Xianju Pharmaceutical

Meloxicam Drugs Segment by Type

Oral Preparations

Topical Preparations

Injections

Meloxicam Drugs Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Meloxicam Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meloxicam Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meloxicam Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meloxicam Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meloxicam Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meloxicam Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Meloxicam Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Meloxicam Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Meloxicam Drugs Industry Trends Table 2. Meloxicam Drugs Industry Drivers Table 3. Meloxicam Drugs Industry Opportunities and Challenges Table 4. Meloxicam Drugs Industry Restraints Table 5. Global Meloxicam Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Meloxicam Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Meloxicam Drugs Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Meloxicam Drugs Sales Market Share by Manufacturers Table 9. Global Meloxicam Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Meloxicam Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Meloxicam Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Meloxicam Drugs Manufacturers, Product Type & Application Table 13. Global Meloxicam Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Meloxicam Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Preparations Table 17. Major Manufacturers of Topical Preparations Table 18. Major Manufacturers of Injections Table 19. Global Meloxicam Drugs Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 21. Global Meloxicam Drugs Sales by Type (2027-2032) & (W Units) Table 22. Global Meloxicam Drugs Sales Market Share by Type (2021-2026) Table 23. Global Meloxicam Drugs Sales Market Share by Type (2027-2032) Table 24. Global Meloxicam Drugs Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Meloxicam Drugs Revenue by Type (2021-2026) & (W Units) Table 26. Global Meloxicam Drugs Revenue by Type (2027-2032) & (W Units) Table 27. Global Meloxicam Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Meloxicam Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacy Table 30. Major Manufacturers of Online Pharmacy Table 31. Major Manufacturers of Retail Pharmacy Table 32. Global Meloxicam Drugs Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 34. Global Meloxicam Drugs Sales by Application (2027-2032) & (W Units) Table 35. Global Meloxicam Drugs Sales Market Share by Application (2021-2026) Table 36. Global Meloxicam Drugs Sales Market Share by Application (2027-2032) Table 37. Global Meloxicam Drugs Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Meloxicam Drugs Revenue by Application (2021-2026) & (W Units) Table 39. Global Meloxicam Drugs Revenue by Application (2027-2032) & (W Units) Table 40. Global Meloxicam Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Meloxicam Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Meloxicam Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Meloxicam Drugs Sales by Region (2021-2026) & (W Units) Table 44. Global Meloxicam Drugs Sales Market Share by Region (2021-2026) Table 45. Global Meloxicam Drugs Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Meloxicam Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 49. North America Meloxicam Drugs Sales by Country (2027-2032) & (W Units) Table 50. Europe Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 52. Europe Meloxicam Drugs Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Meloxicam Drugs Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Meloxicam Drugs Sales by Country (2027-2032) & (W Units) Table 59. Global Meloxicam Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Meloxicam Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Meloxicam Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Meloxicam Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Meloxicam Drugs Revenue Market Share by Region (2027-2032) Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Meloxicam Drugs Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. Iroko Pharmaceuticals Company Information Table 70. Iroko Pharmaceuticals Business Overview Table 71. Iroko Pharmaceuticals Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio Table 73. Iroko Pharmaceuticals Recent Development Table 74. Lupin Company Information Table 75. Lupin Business Overview Table 76. Lupin Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Lupin Meloxicam Drugs Product Portfolio Table 78. Lupin Recent Development Table 79. Nipro Company Information Table 80. Nipro Business Overview Table 81. Nipro Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Nipro Meloxicam Drugs Product Portfolio Table 83. Nipro Recent Development Table 84. Novitium Pharma Company Information Table 85. Novitium Pharma Business Overview Table 86. Novitium Pharma Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novitium Pharma Meloxicam Drugs Product Portfolio Table 88. Novitium Pharma Recent Development Table 89. Zydus Company Information Table 90. Zydus Business Overview Table 91. Zydus Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Zydus Meloxicam Drugs Product Portfolio Table 93. Zydus Recent Development Table 94. Jiangsu Jibeier Pharmaceutical Company Information Table 95. Jiangsu Jibeier Pharmaceutical Business Overview Table 96. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio Table 98. Jiangsu Jibeier Pharmaceutical Recent Development Table 99. Kelun Pharmaceutical Company Information Table 100. Kelun Pharmaceutical Business Overview Table 101. Kelun Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Kelun Pharmaceutical Meloxicam Drugs Product Portfolio Table 103. Kelun Pharmaceutical Recent Development Table 104. Luye Pharma Company Information Table 105. Luye Pharma Business Overview Table 106. Luye Pharma Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Luye Pharma Meloxicam Drugs Product Portfolio Table 108. Luye Pharma Recent Development Table 109. Qilu Pharmaceutical Company Information Table 110. Qilu Pharmaceutical Business Overview Table 111. Qilu Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Qilu Pharmaceutical Meloxicam Drugs Product Portfolio Table 113. Qilu Pharmaceutical Recent Development Table 114. Simcere Pharmaceutical Company Information Table 115. Simcere Pharmaceutical Business Overview Table 116. Simcere Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Simcere Pharmaceutical Meloxicam Drugs Product Portfolio Table 118. Simcere Pharmaceutical Recent Development Table 119. Yangtze River Pharmaceutical Company Information Table 120. Yangtze River Pharmaceutical Business Overview Table 121. Yangtze River Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio Table 123. Yangtze River Pharmaceutical Recent Development Table 124. YaoPharma Company Information Table 125. YaoPharma Business Overview Table 126. YaoPharma Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. YaoPharma Meloxicam Drugs Product Portfolio Table 128. YaoPharma Recent Development Table 129. Zhejiang Xianju Pharmaceutical Company Information Table 130. Zhejiang Xianju Pharmaceutical Business Overview Table 131. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio Table 133. Zhejiang Xianju Pharmaceutical Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Meloxicam Drugs Distributors List Table 137. Meloxicam Drugs Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Meloxicam Drugs Product Image Figure 2. Global Meloxicam Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meloxicam Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Meloxicam Drugs Sales (2021-2032) & (W Units) Figure 5. Global Meloxicam Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Meloxicam Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Preparations Image Figure 9. Topical Preparations Image Figure 10. Injections Image Figure 11. Global Meloxicam Drugs Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Meloxicam Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Meloxicam Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Meloxicam Drugs Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Meloxicam Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Meloxicam Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Global Meloxicam Drugs Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Meloxicam Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Meloxicam Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Meloxicam Drugs Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Meloxicam Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Meloxicam Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Meloxicam Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Meloxicam Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Meloxicam Drugs Sales Market Share by Country (2021-2032) Figure 40. China Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Meloxicam Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Meloxicam Drugs Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Meloxicam Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Meloxicam Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Meloxicam Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Meloxicam Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Meloxicam Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Meloxicam Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Meloxicam Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Meloxicam Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Preparations
  • Topical Preparations
  • Injections
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Boehringer Ingelheim
  • Iroko Pharmaceuticals
  • Lupin
  • Nipro
  • Novitium Pharma
  • Zydus
  • Jiangsu Jibeier Pharmaceutical
  • Kelun Pharmaceutical
  • Luye Pharma
  • Qilu Pharmaceutical
  • Simcere Pharmaceutical
  • Yangtze River Pharmaceutical
  • YaoPharma
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Meloxicam Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Meloxicam Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Meloxicam Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Meloxicam Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Meloxicam Drugs Market Dynamics
  1. 2.1 Meloxicam Drugs Industry Trends
  2. 2.2 Meloxicam Drugs Industry Drivers
  3. 2.3 Meloxicam Drugs Industry Opportunities and Challenges
  4. 2.4 Meloxicam Drugs Industry Restraints
3 Meloxicam Drugs Market by Manufacturers
  1. 3.1 Global Meloxicam Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Meloxicam Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Meloxicam Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Meloxicam Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meloxicam Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Meloxicam Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Meloxicam Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meloxicam Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meloxicam Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meloxicam Drugs Tier 1, Tier 2, and Tier 3
4 Meloxicam Drugs Market by Type
  1. 4.1 Meloxicam Drugs Type Introduction
  2. 4.1.1 Oral Preparations
  3. 4.1.2 Topical Preparations
  4. 4.1.3 Injections
  5. 4.2 Global Meloxicam Drugs Sales by Type
  6. 4.2.1 Global Meloxicam Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meloxicam Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Meloxicam Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Meloxicam Drugs Revenue by Type
  10. 4.3.1 Global Meloxicam Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meloxicam Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Meloxicam Drugs Revenue Market Share by Type (2021-2032)
5 Meloxicam Drugs Market by Application
  1. 5.1 Meloxicam Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Meloxicam Drugs Sales by Application
  6. 5.2.1 Global Meloxicam Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meloxicam Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Meloxicam Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Meloxicam Drugs Revenue by Application
  10. 5.3.1 Global Meloxicam Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Meloxicam Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Meloxicam Drugs Revenue Market Share by Application (2021-2032)
6 Global Meloxicam Drugs Sales by Region
  1. 6.1 Global Meloxicam Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meloxicam Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Meloxicam Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Meloxicam Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Meloxicam Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Meloxicam Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Meloxicam Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Meloxicam Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Meloxicam Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Meloxicam Drugs Revenue by Region
  1. 7.1 Global Meloxicam Drugs Revenue by Region
  2. 7.1.1 Global Meloxicam Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Meloxicam Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Meloxicam Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Meloxicam Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Meloxicam Drugs Revenue (2021-2032)
  8. 7.2.2 North America Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Meloxicam Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Meloxicam Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Meloxicam Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Meloxicam Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Meloxicam Drugs Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Iroko Pharmaceuticals
  8. 8.2.1 Iroko Pharmaceuticals Company Information
  9. 8.2.2 Iroko Pharmaceuticals Business Overview
  10. 8.2.3 Iroko Pharmaceuticals Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio
  12. 8.2.5 Iroko Pharmaceuticals Recent Developments
  13. 8.3 Lupin
  14. 8.3.1 Lupin Company Information
  15. 8.3.2 Lupin Business Overview
  16. 8.3.3 Lupin Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lupin Meloxicam Drugs Product Portfolio
  18. 8.3.5 Lupin Recent Developments
  19. 8.4 Nipro
  20. 8.4.1 Nipro Company Information
  21. 8.4.2 Nipro Business Overview
  22. 8.4.3 Nipro Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nipro Meloxicam Drugs Product Portfolio
  24. 8.4.5 Nipro Recent Developments
  25. 8.5 Novitium Pharma
  26. 8.5.1 Novitium Pharma Company Information
  27. 8.5.2 Novitium Pharma Business Overview
  28. 8.5.3 Novitium Pharma Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novitium Pharma Meloxicam Drugs Product Portfolio
  30. 8.5.5 Novitium Pharma Recent Developments
  31. 8.6 Zydus
  32. 8.6.1 Zydus Company Information
  33. 8.6.2 Zydus Business Overview
  34. 8.6.3 Zydus Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Meloxicam Drugs Product Portfolio
  36. 8.6.5 Zydus Recent Developments
  37. 8.7 Jiangsu Jibeier Pharmaceutical
  38. 8.7.1 Jiangsu Jibeier Pharmaceutical Company Information
  39. 8.7.2 Jiangsu Jibeier Pharmaceutical Business Overview
  40. 8.7.3 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio
  42. 8.7.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  43. 8.8 Kelun Pharmaceutical
  44. 8.8.1 Kelun Pharmaceutical Company Information
  45. 8.8.2 Kelun Pharmaceutical Business Overview
  46. 8.8.3 Kelun Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kelun Pharmaceutical Meloxicam Drugs Product Portfolio
  48. 8.8.5 Kelun Pharmaceutical Recent Developments
  49. 8.9 Luye Pharma
  50. 8.9.1 Luye Pharma Company Information
  51. 8.9.2 Luye Pharma Business Overview
  52. 8.9.3 Luye Pharma Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Luye Pharma Meloxicam Drugs Product Portfolio
  54. 8.9.5 Luye Pharma Recent Developments
  55. 8.10 Qilu Pharmaceutical
  56. 8.10.1 Qilu Pharmaceutical Company Information
  57. 8.10.2 Qilu Pharmaceutical Business Overview
  58. 8.10.3 Qilu Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qilu Pharmaceutical Meloxicam Drugs Product Portfolio
  60. 8.10.5 Qilu Pharmaceutical Recent Developments
  61. 8.11 Simcere Pharmaceutical
  62. 8.11.1 Simcere Pharmaceutical Company Information
  63. 8.11.2 Simcere Pharmaceutical Business Overview
  64. 8.11.3 Simcere Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Simcere Pharmaceutical Meloxicam Drugs Product Portfolio
  66. 8.11.5 Simcere Pharmaceutical Recent Developments
  67. 8.12 Yangtze River Pharmaceutical
  68. 8.12.1 Yangtze River Pharmaceutical Company Information
  69. 8.12.2 Yangtze River Pharmaceutical Business Overview
  70. 8.12.3 Yangtze River Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio
  72. 8.12.5 Yangtze River Pharmaceutical Recent Developments
  73. 8.13 YaoPharma
  74. 8.13.1 YaoPharma Company Information
  75. 8.13.2 YaoPharma Business Overview
  76. 8.13.3 YaoPharma Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 YaoPharma Meloxicam Drugs Product Portfolio
  78. 8.13.5 YaoPharma Recent Developments
  79. 8.14 Zhejiang Xianju Pharmaceutical
  80. 8.14.1 Zhejiang Xianju Pharmaceutical Company Information
  81. 8.14.2 Zhejiang Xianju Pharmaceutical Business Overview
  82. 8.14.3 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio
  84. 8.14.5 Zhejiang Xianju Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meloxicam Drugs Value Chain Analysis
  2. 9.1.1 Meloxicam Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meloxicam Drugs Production Mode & Process
  6. 9.2 Meloxicam Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meloxicam Drugs Distributors
  9. 9.2.3 Meloxicam Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst